Apellis Pharmaceuticals Non-Current Deferred Liabilities (Quarterly) Analysis

Apellis Pharmaceuticals, Inc. (APLS)

20.31 -1.02 (-4.78%) USD | NASDAQ | Jan 14, 16:00

20.50 +0.19 (+0.94%) After-Hours: 17:47

View Non-Current Deferred Liabilities (Quarterly) for APLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

Biogen, Inc.	Upgrade
Amicus Therapeutics, Inc.	--
Fortress Biotech, Inc.	--
Ultragenyx Pharmaceutical, Inc.	Upgrade
Fulcrum Therapeutics, Inc.	--